Marcus Center for Cellular Cures
Hospitals & Physicians Clinics · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2400 Pratt St, Durham, North Carolina, 2...Website
marcuscenter.duke.eduRevenue
$12.4 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Marcus Center for Cellular Cures
The Duke Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine focuses on developing cellular and biological therapies for conditions such as autism, cerebral palsy, stroke, and multiple sclerosis. It collaborates with the Pratt School of Engineering to harness technology in the field of medicine. The center is supported by the Marcus Foundation, which has contributed generously over the years. Its intended clients include patients suffering from various brain disorders.Explore more
Marcus Center for Cellular Cures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Marcus Center for Cellular Cures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Marcus Center for Cellular Cures recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Marcus Center for Cellular Cures
Marcus Center for Cellular Cures, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Marcus Center for Cellular Cures had a recent Job posting/layoffs
Product Launch: Get notified when Marcus Center for Cellular Cures launches new products
Website visits: Recent activity has been detected on your website
Check out if Marcus Center for Cellular Cures is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Marcus Center for Cellular Cures has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Marcus Center for Cellular Cures has new funding data
Recommended Actions
Find VP level buyers at Marcus Center for Cellular Cures
Find 3 more new buyers
Compare Similar Companies to Marcus Center for Cellular Cures
Compare insights from companies similar to Marcus Center for Cellular Cures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
Marcus Center for Cellular Cures is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Marcus Center for Cellular Cures is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Marcus Center for Cellular Cures.
Top Hospitals & Physicians Clinics Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Marcus Center for Cellular Cures
Sign Up For FreeTo access detailed company insights
The Duke Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine focuses on developing cellular and biological therapies for conditions such as autism, cerebral palsy, stroke, and multiple sclerosis. It collaborates with the Pratt School of Engineering to harness technology in the field of medicine. The center is supported by t... Read More
